| Similar Articles |
|---|
 |
Chemistry World
August 20, 2013
Phillip Broadwith |
Boehringer to close manufacturing plants and cut jobs Boehringer Ingelheim is closing two US manufacturing plants, with a combined loss of 690 jobs.   |
Chemistry World
July 29, 2015
Phillip Broadwith |
Hikma boosts generics with Roxane buyout UK-headquartered Hikma Pharmaceuticals has agreed to buy Roxane Laboratories -- Boehringer Ingelheim's generic medicines unit -- for a total of $2.65 billion. |
Fast Company
April 2006
Chuck Salter |
At One With Our Cells A 2005 survey of 3,000 cell-phone users, ages 15 to 35, in 15 countries revealed an almost frightening culture of dependency. |
Chemistry World
June 24, 2011
Hepeng Jia |
Pharma pollution is out of control in China Active pharmaceutical ingredients pollution problems seem to continue even after the Chinese government increased efforts to reduce environmental pollution from drug makers. |
Chemistry World
July 1, 2013
Laura Howes |
Aspen in $1 billion deal with Merck The deal involves 11 of Merck's drug brands and an active pharmaceutical ingredient business in the Netherlands. |
Chemistry World
September 17, 2012
Andrew Turley |
Drug discovery becomes Facebook game German drug maker Boehringer Ingelheim has launched a game based on the drug discovery process. |
Chemistry World
September 26, 2012
Andrew Turley |
Boehringer drops virology R&D German pharma company Boehringer Ingelheim is to close its R&D site in Laval, Canada, in early 2013, with the loss of 170 jobs. |
Chemistry World
October 23, 2009
Matt Wilkinson |
What's in a pill? Buying cheap drugs over the internet is well known to be a risky business. But the sinister menace of the 'falsified' active pharmaceutical ingredient gets far less publicity. |
BusinessWeek
July 8, 2010 |
Hard Choices: Betting on China's Startups Kai-Fu Lee, the founding president of Google China talks about leaving fertile Silicon Valley to invest in promising new Chinese companies. |
The Motley Fool
January 30, 2007
Brian Lawler |
Is Bigger Better for Abbott Labs? Abbott continues its transformation into a more focused pharmaceutical powerhouse. But shares of this pharmaceutical aren't exactly cheap. |
Chemistry World
May 23, 2012
Andy Extance |
Drug watchdogs mark out global territory The US Food and Drug Administration has published plans to ensure that American citizens continue to enjoy access to safe drugs, even as the regulatory pressures of globalization grow. |
Bio-IT World
July 15, 2003 |
Solutia Streamlines Route from Lab to Production Solutia Pharmaceutical Services, under pressure to control costs, built a single, integrated software application that enables management and control of every resource used in the development and manufacture of API (active pharmaceutical ingredient) products. |
InternetNews
January 14, 2010 |
Google Shines a Light on China's Record So many vendors were anxious to get a piece of the Chinese market. Google is making some people wonder if it's worth it. |
Search Engine Watch
May 4, 2011
Andy Atkins-Kruger |
Should Google Escape the Death Spiral in China by 'Losing Face'? Weighing which of four paths Google should take when it comes to China: promote within China but remain in Hong Kong; do something completely different; re-enter China; or do nothing. |
The Motley Fool
January 27, 2005
Selena Maranjian |
Getting Into Closed Funds There's no need to stress out if you're locked out of a good fund. |
Entrepreneur
May 2005
Mark Henricks |
Eastern Influence Chinese companies are becoming increasingly active in buying, merging with and doing joint ventures with smaller U.S companies -- usually in search of technology. |
